Pelvic lymphadenectomy for prostate cancer is an important tool in the prognostication of the disease in selected patients who are at risk of occult lymph node metastases. This procedure, usually performed in conjunction with radical prostatectomy, had progressed successfully from an open approach to the current robot-assisted approach. The following article and accompanying video describe the surgical technique of robot-assisted pelvic lymphadenectomy for prostate cancer. We also discuss the indications, patient selection, preparation, complications, and tips to avoid the major pitfalls in the procedure.
Get full access to this article
View all access options for this article.
References
1.
SchuesslerWW, VancaillieTG, ReichH, GriffithDP. Transperitoneal endosurgical lymphadenectomy in patients with localized prostate cancer. J Urol, 1991; 145:988–991.
HeidenreichA, OhlmannCH, PolyakovS. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy. Eur Urol, 2007; 52:29–37.
4.
La RochelleJC, AmlingCL. Role of lymphadenectomy for prostate cancer: Indications and controversies. Urol Clin North Am, 2011; 38:387–395.
5.
Da PozzoLF, CozzariniC, BrigantiAet al.Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: The positive impact of adjuvant radiotherapy. Eur Urol, 2009; 55:1003–1011.
6.
MessingEM, ManolaJ, SarosdyMet al.Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med, 1999; 341:1781–1788.
7.
AllafME, PalapattuGS, TrockBJet al.Anatomical extent of lymph node dissection: Impact on men with clinically localized prostate cancer. J Urol, 2004; 172:1840–1844.
8.
JoslynSA, KonetyBR. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology, 2006; 68:121–125.
9.
D'AmicoAV, WhittingtonR, MalkowiczSBet al.Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA, 1998; 280:969–974.
10.
HeidenreichA, VargaZ, Von KnoblochR. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: High incidence of lymph node metastasis. J Urol, 2002; 167:1681–1686.
11.
SchumacherMC, BurkhardFC, ThalmannGNet al.Is pelvic lymph node dissection necessary in patients with a serum PSA <10ng/ml undergoing radical prostatectomy for prostate cancer?Eur Urol, 2006; 50:272–279.
12.
BollaM, ColletteL, BlankLet al.Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial. Lancet, 2002; 360:103–106.
13.
HanksGE, PajakTF, PorterAet al.Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02. J Clin Oncol, 2003; 21:3972–3978.
14.
BoorjianSA, ThompsonRH, SiddiquiSet al.Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. J Urol, 2007; 178:864–871.
15.
EngelJ, BastianPJ, BaurHet al.Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer. Eur Urol, 2010; 57:754–761.
16.
LattoufJB, BeriA, JeschkeSet al.Laparoscopic extended pelvic lymph node dissection for prostate cancer: Description of the surgical technique and initial results. Eur Urol, 2007; 52:1347–1355.
17.
StoneNN, StockRG, UngerP. Laparoscopic pelvic lymph node dissection for prostate cancer: Comparison of the extended and modified techniques. J Urol, 1997; 158:1891–1894.
18.
DavisJW, ShahJB, AchimM. Robot-assisted extended pelvic lymph node dissection (PLND) at the time of radical prostatectomy (RP): A video-based illustration of technique, results, and unmet patient selection needs. BJU Int, 2011; 108:993–998.
19.
YuhBE, RuelNH, MejiaRet al.Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer. Eur Urol, 2012; 61:1004–1010.
20.
OrvietoMA, CoelhoRF, ChauhanSet al.Incidence of lymphoceles after robot-assisted pelvic lymph node dissection. BJU Int, 2011; 108:1185–1190.
21.
BaderP, BurkhardFC, MarkwalderR, StuderUE. Is a limited lymph node dissection an adequate staging procedure for prostate cancer?J Urol, 2002; 168:514–518.
22.
GanswindtU, PaulsenF, CorvinSet al.Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition. BMC Cancer, 2005; 5:91.
23.
GanswindtU, PaulsenF, CorvinSet al.Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy technique. Int J Radiat Oncol Biol Phys, 2007; 67:347–355.
24.
MatteiA, FuechselFG, Bhatta DharNet al.The template of the primary lymphatic landing sites of the prostate should be revisited: Results of a multimodality mapping study. Eur Urol, 2008; 53:118–125.
25.
DevilleC, VapiwalaN, HwangWTet al.Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy. Int J Radiat Oncol Biol Phys, 2012; 82:1389–1396.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
